Glenmede Trust’s Immatics IMTX Stock Holding History

Glenmede Trust’s Portfolio IMTX Stock Details IMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-270	Closed	-$2K	–	1708
2020 Q3	$2K	Buy	+270	New	+$2.84K	﹤0.01%	2265

Other funds holding IMTX

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Alyeska Investment Group

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Federated Hermes

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Glenmede Trust's IMTX Position: Q4 2020 in Review

Glenmede Trust sold out of Immatics (IMTX) in Q4 2020, closing a stake of 270 shares — an estimated $2K sold.

Glenmede Trust first reported a position in IMTX in Q3 2020 and held it in 1 quarter. The position peaked at $2K in Q3 2020. 41 funds tracked by Wall St. Rank hold IMTX as of Q4 2020.

Glenmede Trust reported no remaining Immatics position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 270 Immatics shares in Q4 2020, an estimated $2K.
Glenmede Trust first reported a position in Immatics in Q3 2020 and held it in 1 quarter.
Glenmede Trust's Immatics position peaked at $2K in Q3 2020.
41 funds tracked by Wall St. Rank held Immatics as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.